All Type of News
Ethics management issue draws varying reactions
In a recent seminar, the Fair Trade Commission and the Korea Research-based Pharmaceutical Industry Association (KRPIA) disclosed varying views with respect to their approaches to the ethics management of pharmaceutic...
Teams up for development of core pharmaceutical intermediates
Dasan Medicam, a local research-oriented pharmaceutical marker, is gearing up to take on Pfizer's Lipitor.
Targeting a bigger share in the domestic statin-based drugs market, Dasan has formed a strategic alliance w...
Doctors raked up 1.3 trillion won with bioequivalence-unproven drugs
With a total of 567 drugs whose bioequivalence testing has been unproven or falsified, doctors' claims for medical reimbursement has amounted to 1.3 trillion for the recent three years, according to data released by t...
Merck KGaA to invest 14 billion won in Korea
Merck KGaA, the world's leading supplier of liquid crystals, will invest 14 billion won to establish its advanced technology center in Korea on January 2008 as part of its plan to expand its position in the domestic l...
Lotte Confectionary to advertise functional gum
Lotte Confectionary plans to promote its functional gum via mass media to bite into pharmacy market in hopes of stealing patients' appetite.
Industry experts have noted an overall shift in the nation's food and dri...
KPMA to support scientific events by third party
The Korea Pharmaceutical Manufacturers Association will sign a memorandum of understanding (MOU) with the Korean Institute of Medicine and the Korean Medical & Scientific Assistance Foundation on February 26 in a move...
FTC to look into drug makersKorea's antitrust regulator will re-embark on looking into the drug makers' undue business practices such as joint marketing.
The Fair Trade Commission (FTC) said on January ...
|
Domestic, foreign drug makers moving to join hands over low-priced drug incentive plan
Korean drug makers and multinationals will be likely to join hands to cope with the government's plan to pass a bill aiming at introducing the controversial incentive system for medical institution's low-priced drug p...
Drug classification shows bigger differences, health ministry says
The Ministry of Health and Welfare has yet to narrow differences over the scope of newly modified drugs, according to goverment sources.
The ministry officials said that they cannot make a definite definition over ...
Daewoong hires ex-Amore Pacific research headDaewoong Pharm said it has recently hired former Amore Pacific research chief Kim Chung-joo as its laboratory head in charge of lifescience engineering.
A graduate of Seoul N...
|
